Investigational Drug Information for Fluoropyrimidine
✉ Email this page to a colleague
What is the development status for investigational drug Fluoropyrimidine?
Fluoropyrimidine is an investigational drug.
There have been 285 clinical trials for Fluoropyrimidine.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 30th 2018.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Eli Lilly and Company, and Hoffmann-La Roche.
There are seven hundred and ninety-nine US patents protecting this investigational drug and seven international patents.
Summary for Fluoropyrimidine
| US Patents | 799 |
| International Patents | 7,565 |
| US Patent Applications | 2,735 |
| WIPO Patent Applications | 1,496 |
| Japanese Patent Applications | 894 |
| Clinical Trial Progress | Phase 3 (2018-07-30) |
| Vendors | 82 |
Recent Clinical Trials for Fluoropyrimidine
| Title | Sponsor | Phase |
|---|---|---|
| The Efficacy and Safety of Fruquintinib Plus FOLFIRI as Second-line Treatment in RAS-mutated Metastatic Colorectal Cancer | Hunan Cancer Hospital | Phase 2 |
| ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer | MEI Pharma, Inc. | Phase 1 |
| mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma | National Cancer Institute (NCI) | Phase 3 |
Clinical Trial Summary for Fluoropyrimidine
Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine
US Patents for Fluoropyrimidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluoropyrimidine | ⤷ Try a Trial | Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) | ⤷ Try a Trial |
| Fluoropyrimidine | ⤷ Try a Trial | Combination therapies for cancer | MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH) | ⤷ Try a Trial |
| Fluoropyrimidine | ⤷ Try a Trial | Tapered looped suture | Covidien LP (Mansfield, MA) | ⤷ Try a Trial |
| Fluoropyrimidine | ⤷ Try a Trial | Methods of enhancing antibody-dependent cellular cytotoxicity | VentiRx Pharmaceuticals, Inc. (Seattle, WA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluoropyrimidine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluoropyrimidine | World Intellectual Property Organization (WIPO) | WO2013071079 | 2031-11-09 | ⤷ Try a Trial |
| Fluoropyrimidine | European Patent Office | EP3003316 | 2033-05-31 | ⤷ Try a Trial |
| Fluoropyrimidine | Spain | ES2822665 | 2033-05-31 | ⤷ Try a Trial |
| Fluoropyrimidine | Hong Kong | HK1223552 | 2033-05-31 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
